Newsletter | November 7, 2024

11.07.24 -- Why Aren't More Sites Moving To eSource?

FEATURED EDITORIAL

Why Aren't More Sites Moving To eSource?

In this segment, TF Pharma's Robert Goldman talks about different views of what eSource is and how, in some instances, this clinical trial technology doesn’t save any time over using paper.

INDUSTRY INSIGHTS

Outsourcing Data Management: Challenges And Benefits

Life sciences companies are grappling with a deluge of data. Yet, strategic data management outsourcing offers potential benefits amidst regulatory and interoperability hurdles.

eConsent: The Missing Ingredient To More Engaging Clinical Trials

Electronic consent promotes better trial experiences, but many sites and sponsors are wary of giving up paper-based processes. Consider their reasons for caution and how teams can prepare for the switch.

Benefits Of Delegating The Patient Screening Process For Oncology Trials

Explore the integration of Electronic Health Records (EHR) into oncology clinical trials, highlighting both challenges and potential advancements.

QT Monitoring Impacts More Than Just Cardiac Health

Achieve earlier detection of potential adverse cardiac events and refine patient selection for future trial phases by implementing advanced QT monitoring tools.

Revolutionizing Pediatric Clinical Trials With ePRO And eConsent

Digital tools like ePRO and eConsent are essential in addressing pediatric trial challenges such as the diverse participant ages and family involvement, which impact retention and data quality.

Transforming Patient Support For A Multinational Pharmaceutical Company

As part of an expansion project, a large multinational pharmaceutical company sought a partner to simplify the payment and travel processes, improving their patients' experience.

How A Dedicated Medical Affairs Team Drives Site Engagement

See how improvements made to SIP have allowed for quick access to study documents and bulk actions for streamlined document management and enhanced user experience.